GlassScriptPhysician profile
Aditya Mehta
NPI 1679964324
$2,590.25
in general payments reported to CMS, 2019-2025
12 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2021: $296 · 2022: $202 · 2023: $192 · 2024: $94.98 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,291 · Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,291.01 |
| Food and Beverage | $352.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,599.37 | 2022-2025 | 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Alcon Vision LLC | $423.32 | 2019-2024 | Centurion |
| Alexion Pharmaceuticals, INC. | $123.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.04 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $109.50 | 2019 | |
| Getinge USA Sales, LLC | $49.64 | 2022 | |
| Ocular Therapeutix, INC. | $49.30 | 2019 | |
| Sight Sciences, INC. | $39.81 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Abbvie INC. | $29.69 | 2023 | |
| Sun Pharmaceutical Industries INC. | $20.40 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.35 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.